ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $166,000 | -20.2% | 47,800 | -46.9% | 0.00% | -50.0% |
Q4 2018 | $208,000 | +477.8% | 90,100 | +663.6% | 0.00% | – |
Q1 2016 | $36,000 | -98.0% | 11,800 | -97.5% | 0.00% | -100.0% |
Q4 2015 | $1,810,000 | +132.9% | 470,197 | +520.5% | 0.01% | +42.9% |
Q2 2014 | $777,000 | -43.2% | 75,781 | -33.5% | 0.01% | -46.2% |
Q1 2014 | $1,369,000 | -19.3% | 113,977 | -24.0% | 0.01% | +18.2% |
Q4 2013 | $1,697,000 | – | 150,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |